Ella Therapeutics

Ella Therapeutics
Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.
About
What does Ella Therapeutics do?
Ella Therapeutics is a biotechnology company focused on developing novel microbiome-derived therapies to address resistance to immune checkpoint inhibitors (ICIs) in cancer treatment. Their research utilizes a unique Reverse Clinical Development method to identify and characterize specific microbial agents that can enhance the efficacy of existing cancer immunotherapies.
What is Ella Therapeutics's revenue?
StartupHub estimates Ella Therapeutics's annual revenue at $687K (range $381K to $1.1M, 64% confidence), based on comparable companies in the sector.
Where is Ella Therapeutics headquartered?
Ella Therapeutics is headquartered in Boston, United States.
When was Ella Therapeutics founded?
Ella Therapeutics was founded in 2019.
What industry does Ella Therapeutics operate in?
Ella Therapeutics operates in Life Sciences, Immunotherapy, Microbiome, Computational Biology, Healthcare, Biotech.
How many employees does Ella Therapeutics have?
Ella Therapeutics has approximately 4 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.